Light Mode
$5.76 ↓ -0.05 (-0.78%) Trading Down from the previous close of $5.81
-1.29 (-18.12%) / 6M
Momentum, market sentiment, and recent alerts
STTK reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +197.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.